EPC•Edgewell Personal Care’s fiscal Q4 sales rose 3% to $484.1 million, slightly above estimates, while adjusted EPS increased 50% to $0.78 and beat estimates. For fiscal 2027, the company expects sales growth of 0.4% to 2.4% and adjusted EPS of $1.85 to $2.15.
Fiscal Q4 organic sales rose 3.1%, with growth in North America and international markets. Adjusted gross margin increased 510 basis points, supported by productivity savings, volume absorption, favorable currency and the comparison with transitory costs; higher inflation and unfavorable mix partly offset those factors. The company also increased advertising and sales promotion expense.
Edgewell expects reported net sales to rise 0.4% to 2.4% in fiscal 2027, adjusted EPS of $1.85 to $2.15, and adjusted EBITDA of $250 million to $270 million.
